Trospium News and Research

RSS
Trospium is a urinary antispasmodic. It is sold under the brand name Sanctura in the US, Trosec in Canada, Regurin in the United Kingdom and Spasmex in Israel.
No added benefit determined from Mirabegron for mortality, morbidity and quality of life

No added benefit determined from Mirabegron for mortality, morbidity and quality of life

Perrigo receives final approval for generic Sanctura XR

Perrigo receives final approval for generic Sanctura XR

Antimuscarinics only moderately effective for overactive bladder

Antimuscarinics only moderately effective for overactive bladder

US Court of Appeals confirms District Court decision in Watson's Sanctura XR patent suit

US Court of Appeals confirms District Court decision in Watson's Sanctura XR patent suit

Allergan reports operating results for the third quarter of 2009

Allergan reports operating results for the third quarter of 2009

Quintiles Transnational enter into marketing agreement with Allergan for SANCTURA XR

Quintiles Transnational enter into marketing agreement with Allergan for SANCTURA XR

Regurin XL capsule for the treatment of OAB launched in UK

Regurin XL capsule for the treatment of OAB launched in UK

Watson confirms new drug application for generic Sanctura XR

Watson confirms new drug application for generic Sanctura XR

Commonly prescribed incontinence drug may help control symptoms of overactive bladder

Commonly prescribed incontinence drug may help control symptoms of overactive bladder

Indevus announces agreement with Pliva for overactive bladder treatment drug

Indevus announces agreement with Pliva for overactive bladder treatment drug